An mRNA vaccine elicits STING-dependent antitumor immune responses.

Chen, Zhe; Meng, Chaoyang; Mai, Junhua; Liu, Yongbin; Li, Hangwen; Shen, Haifa

Chen, Zhe; Meng, Chaoyang; Mai, Junhua; Liu, Yongbin; Li, Hangwen; Shen, Haifa.

Afiliação

Chen Z; Department of Nanomedicine, Houston Methodist Academic Institute, Houston, TX 77030, USA.
Meng C; Xiangya Hospital of Central South University, Changsha 410000, China.
Mai J; Department of Nanomedicine, Houston Methodist Academic Institute, Houston, TX 77030, USA.
Liu Y; Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Li H; Department of Nanomedicine, Houston Methodist Academic Institute, Houston, TX 77030, USA.
Shen H; Department of Nanomedicine, Houston Methodist Academic Institute, Houston, TX 77030, USA.

Acta Pharm Sin B ; 13(3): 1274-1286, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36970194

Palavras-chave

Cancer; Dendritic cells; EDOPC; Immunotherapy; MAVS; STING; Vaccine; mRNA

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Acta Pharm Sin B Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google